Pfizer-BioNTech's COVID-19 vaccine shows 100% effectiveness in adolescents
Pfizer-BioNTech's BNT162b2 COVID-19 vaccine demonstrated 100% efficacy and robust antibody responses in people between the ages of 12 and 15, according to results from a phase III trial. Read More
Unchained Labs adds automated gene therapy, vaccine applications
Unchained Labs has rolled out new gene therapy and vaccine applications on its Big Tuna automated buffer exchange platform for biologics. The system can now buffer adeno-associated viruses and lipid nanoparticles. Read More
Charles River acquires Retrogenix for $48M
Charles River Laboratories has paid approximately $48 million U.S. to acquire the U.K.-based contract research organization Retrogenix. Read More
Thermo Fisher debuts KingFisher Apex sample purification system
Thermo Fisher Scientific launched its new KingFisher Apex Purification System, a high-throughput sample purification instrument designed to automate the extraction of DNA, RNA, proteins, and cells from an array of sample types. Read More
MedTech Innovator launches to help life science startups
MedTech Innovator has launched BioTools Innovator, a funding competition to help life science startups develop and commercialize biotechnology products, platforms, and services. Read More
10x Genomics launches low-throughput gene expression kit
10x Genomics has launched its chromium single-cell gene expression low-throughput kit, a new offering designed to enable single cell analysis. Read More
GSK to provide services for Novavax's COVID-19 vaccine in the U.K.
GlaxoSmithKline (GSK) has signed an agreement in principle to support manufacturing of up to 60 million doses of Novavax's NVX-CoV2373 COVID-19 vaccine candidate for use in the U.K. Read More
Seer, Sciex to provide end-to-end proteomics solutions
Sciex and Seer have inked a nonexclusive commercial agreement. Under the deal, Seer will market Sciex's mass spectrometry systems together with its Proteograph product suite. Read More
BridGene, Takeda partner to discover drugs using chemoproteomics
BridGene Biosciences has entered a strategic research collaboration and licensing agreement with Takeda Pharmaceutical to establish up to five drug discovery programs. Read More
Horizon Discovery offers new CRISPR reagents
Horizon Discovery, a PerkinElmer company, is expanding its gene editing and modulation portfolio to include a new family of CRISPR modulation reagents for CRISPR interference. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
